LncRNA Information | |||||
---|---|---|---|---|---|
ID | EL0094 | Name | AC087857.1 | Aliases | N/A |
Species | Homo sapiens | Chromosome | 3 | Start site | 5962842 |
End site | 6124120 | Chain | plus | Exon NO. | N/A |
Assembly | Ensembl Release 101 | Class | lincRNA | NCBI accession | N/A |
Ensembl | ENSG00000229642 | Sequence | N/A | Peptide-related | N/A |
CircRNA | N/A | Exosomal | N/A | Structure | N/A |
Disease | |||||||||
---|---|---|---|---|---|---|---|---|---|
Disease | Drug/chemo/stress | Method | Sample | Expression pattern | Dysfunction type | Description | PMID | ||
gallbladder cancer | doxorubicin (Dox) | microarray, Knockdown,western blot, RNA pull-down, | gallbladder cancer tissues. | up-regulated | interaction | Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy. | 30953511 |
Interaction | |||||||||
---|---|---|---|---|---|---|---|---|---|
Interaction target | Level of interaction | Type of interaction | Methods | Description | PMID | ||||
PGK1 | RNA-Protein | binding | N/A | GBCDRlnc1 interacts with phosphoglycerate kinase1 and inhibits its ubiquitination in Dox-resistant gallbladder cancer cells, which leads to the down-regulation of autophagy initiator ATG5-ATG12 conjugate. | 30953511 | ||||
Display: |
|